No Data
No Data
No Data
Luxin Venture Capital Group (600783.SH): The company plans to issue Bonds products.
On December 13, Gelonghui reported that Luxin Venture Capital Group (600783.SH) announced that to meet the needs of the company's Operation and ensure the funding demands for its external investment Business, the company will hold the 30th meeting of the 11th Board of Directors on December 13, 2024. The meeting unanimously reviewed and approved the proposal regarding the company's plan to issue Bonds products, with a total registration and issuance scale of various domestic Bonds products not exceeding 1 billion yuan. The funds raised from the Bonds products will be used to replenish working capital and for Private Equity investments. The management team is authorized to determine the application and issuance according to the company's funding needs and market conditions.
Luxin Venture Capital Group (600783.SH): A subsidiary plans to transfer the rights to the share profits of Longli Biotechnology.
Gelonghui, December 13 - Luxin Venture Capital Group (600783.SH) announced that, in order to further reduce the non-performing Assets ratio, its wholly-owned subsidiary ShanDong Gaoxin Investment plans to transfer the income rights corresponding to its 9.79% stake in Longli Biological to ShanDong Jinzi for a price of 4.3962 million yuan.
The State-owned Assets Supervision and Administration Commission, together with the National Development and Reform Commission, jointly introduced a significant venture capital policy, and the equity market is expected to usher in a period of development
1. The State-owned Assets Supervision and Administration Commission of the State Council and the National Development and Reform Commission jointly introduced policy measures to promote the high-quality development of central enterprises' venture capital funds, support central enterprises in initiating the establishment of venture capital funds, focusing on early-stage, small-scale, long-term, and hard technology investments. 2. Citic Sec research reports pointed out that, against the backdrop of entering a valuation expansion cycle in the secondary market, as the linkage effects between the primary and secondary markets become increasingly close, the equity market will also move towards a period of high-quality development and prosperity.
Luxin Venture Capital Group (600783.SH): The company and its affiliated funds did not participate in the investment in Moore Thread.
Luxin Venture Capital Group (600783.SH) stated on the investor interaction platform that the company and its affiliated funds did not participate in the investment in Mole Thread Asia Vets Technology (Beijing) Co., Ltd.
Luxin Venture Capital: Luxin Venture Capital 2024 Third Quarter Report
Luxin Venture Capital 2024 Third Quarter Report